Cathay Biotech Inc. (SHA:688065)
54.21
-0.19 (-0.35%)
At close: Feb 6, 2026
Cathay Biotech Market Cap
Cathay Biotech has a market cap or net worth of 39.07 billion as of February 6, 2026. Its market cap has increased by 80.71% in one year.
Market Cap
39.07B
Enterprise Value
33.96B
Revenue
3.29B
Ranking
n/a
PE Ratio
59.07
Stock Price
54.21
Market Cap Chart
Since August 12, 2020, Cathay Biotech's market cap has decreased from 65.42B to 39.07B, a decrease of -40.28%. That is a compound annual growth rate of -8.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 39.07B | 8.86% |
| Dec 31, 2025 | 35.89B | 59.12% |
| Dec 31, 2024 | 22.56B | -29.54% |
| Dec 29, 2023 | 32.01B | -10.45% |
| Dec 30, 2022 | 35.75B | -53.44% |
| Dec 31, 2021 | 76.79B | 116.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 12, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inner Mongolia Junzheng Energy & Chemical Group | 48.10B |
| Haohua Chemical Science & Technology Corp. | 45.79B |
| Hubei Xingfa Chemicals Group | 41.99B |
| Zhejiang Sanmei Chemical Industry | 41.68B |
| Do-Fluoride New Materials | 34.38B |
| Sunresin New Materials Co.,Ltd | 33.85B |
| Weihai Guangwei Composites | 32.54B |
| Chengxin Lithium Group | 31.83B |